Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital

Archbold Medical Center is accredited by the Commission on Cancer of the American College of Surgeons as a Community Hospital Comprehensive Cancer Program. The center participates in clinical trials involving new therapies and diagnostics. The Lewis Hall Singletary Oncology Center is a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers. The Lewis Hall Singletary Oncology Center, located in Thomasville, Georgia, has served patients from over 45 different counties in Georgia, Florida and Alabama. The cancer center has five medical oncologists and two radiation oncologists. The Lewis Hall Singletary Oncology Center is home to technology and amenities not commonly seen in the region, such as private infusion rooms, the Gamma Knife – non-invasive precision radiosurgery – and a breast cancer patient navigator program.

Treatment Sites in Georgia

Primary Location

919 South Broad Street
Thomasville, GA 31792
229-584-5468 (p)
229-551-8647 (f)
www.archbold.org

driving directions


Archbold Specialty Clinic

1323 E. Shotwell St
Bainbridge, 39819
229-4939968 (p)
229-493-9983 (f)


driving directions


Camilla Clinic

259 US Hwy 19
Camilla, 31730


driving directions

Clinical Trials in Georgia

A Phase 3, Randomized, Double-Blind Study Of PF-05280586 Versus Rituximab For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma
Cancer Type: Non-Hodgkin Lymphoma

A Phase III Double Blind Study On The Efficacy of Topical Aloe Vera Gel on Irradiated Breast Tissue
Cancer Type: Breast Cancer

A Phase III, Open-label, Randomized Study to Investigate the Efficacy and Safety of MPDL3280A (Anti-PD-L1 Antibody) Compared With Best Supportive Care Following Adjuvant Cisplatin-based Chemotherapy in PD-L1-Selected Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer
Cancer Type: Lung Cancer
Study Coordinator: Tiffany Woolum - 229-584-5417


A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
Cancer Type: Breast Cancer

A Registry of Caris Target Now Test Results (Biomarker Expression Patterns) for Evaluation of Correlation with Clinical Outcomes for Cancer
Cancer Type: Multiple Primaries
Study Coordinator: Tiffany Woolum RN, BSN, OCN - 229-584-5417


A Registry of Cesium-131 Brachytherapy Plus Sub- lobar Resection for Early Stage Lung Cancer
Cancer Type: Lung Cancer
Study Coordinator: Tiffany Woolum RN, BSN, OCN - 229-584-5417


A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) (CheckMate370)
Cancer Type: Lung Cancer
Study Coordinator: Tiffany Woolum - 229-584-5417


Studying Interventions for Managing Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase: The 5-Year Prospective Cohort Study (SIMPLICITY)
Cancer Type: Leukemia
Study Coordinator: Tiffany Woolum RN, BSN, OCN - 229-584-5417